JTCS Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Yukito Ichinose
Ryosuke Tsuchiya
Harubumi Kato
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ichinose, Y.
Right arrow Articles by Kato, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ichinose, Y.
Right arrow Articles by Kato, H.
Related Collections
Right arrow Lung - cancer
Right arrow Pleura

J Thorac Cardiovasc Surg 2002;123:695-699
© 2002 The American Association for Thoracic Surgery


General Thoracic Surgery (GTS)

A prematurely terminated phase III trial of intraoperative intrapleural hypotonic cisplatin treatment in patients with resected non-small cell lung cancer with positive pleural lavage cytology: The incidence of carcinomatous pleuritis after surgical intervention

Yukito Ichinose, MDa, Ryosuke Tsuchiya, MDb, Teruaki Koike, MDc, Tsutomu Yasumitsu, MDd, Kenji Nakamura, MDe, Hirohito Tada, MDf, Hirokuni Yoshimura, MDg, Tetsuya Mitsudomi, MDh, Ken Nakagawa, MDi, Kohei Yokoi, MDj, Harubumi Kato, MDk

From the National Kyushu Cancer Center,a Fukuoka; National Cancer Center Hospital,b Tokyo; Niigata Cancer Center Hospital,c Niigata; Osaka Prefectural Habikino Hospital,d Osaka; National Kure Hospital,e Hiroshima; Osaka City General Hospital,f Osaka; Kitazato University,g School of Medicine, Kanagawa; Aichi Cancer Center Hospital,h Aichi; Cancer Institute Hospital,i Tokyo; Tochigi Cancer Center,j Tochigi; and Tokyo Medical University,k Tokyo, Japan.

Supported by a Grant-in-Aid (S11-2) for Cancer Research from the Ministry of Health and Welfare, Japan.

Received for publication June 1, 2001. Revisions requested Aug 28, 2001; revisions received Sept 24, 2001. Accepted for publication Oct 2, 2001. Address for reprints: Yukito Ichinose, MD, Department of Chest Surgery, National Kyushu Cancer Center, 3-1-1, Notame, Minami-ku, Fukuoka 811-1395, Japan (E-mail: yichinos{at}nk-cc.go.jp).

Background: The prognosis of patients with resected non-small cell lung cancer without carcinomatous pleuritis whose intrapleural cancer cells were detected by means of a cytologic examination of pleural lavage fluid obtained immediately after a thoracotomy has been reported to be poor.
Methods: The Japan Clinical Oncology Group conducted a phase III trial for a 3-year period starting from October 1994 to determine whether intraoperative intrapleural hypotonic cisplatin treatment could effectively control pleural disease and thereby prolong the survival of these patients. The patients were randomized to receive either intraoperative intrapleural hypotonic cisplatin treatment or no treatment before closure of the open thorax. The intraoperative intrapleural hypotonic cisplatin treatment consisted of exposing the entire thorax to cisplatin (50 µg/mL) in distilled water for 15 minutes.
Results: Because of the slow registration pace, the study was prematurely terminated in January 1998. During the 41-month period from the start of the registration, 49 patients were entered into the study, and all were eligible. Twenty-five and 24 patients were randomly assigned to the treatment and control groups, respectively. No statistically significant difference in the overall survival and disease-free survival between the 2 groups was observed. However, the appearance of carcinomatous pleuritis was suppressed by the hypotonic cisplatin treatment (42% of the control group vs 8% of the treatment group, P = .008).
Conclusions: Although the randomized trial was prematurely terminated, the intraoperative intrapleural hypotonic cisplatin treatment was found to effectively suppress the appearance of carcinomatous pleuritis in resected patients who demonstrated a positive pleural lavage cytology finding.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
E. Lim
Invited commentary
Ann. Thorac. Surg., January 1, 2007; 83(1): 202 - 203.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Nakagawa, N. Okumura, Y. Kokado, K. Miyoshi, T. Matsuoka, and K. Kameyama
Clinical Relevance of Intraoperative Pleural Lavage Cytology in Non-Small Cell Lung Cancer
Ann. Thorac. Surg., January 1, 2007; 83(1): 204 - 208.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. Maruyama, F. Shoji, T. Okamoto, T. Miyamoto, T. Miyake, T. Nakamura, J. Ikeda, H. Asoh, M. Yamaguchi, I. Yoshino, et al.
Prognostic value of visceral pleural invasion in resected non-small cell lung cancer diagnosed by using a jet stream of saline solution
J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1587 - 1592.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. Lim, A. Ali, P. Theodorou, A. G. Nicholson, G. Ladas, and P. Goldstraw
Intraoperative pleural lavage cytology is an independent prognostic indicator for staging non-small cell lung cancer
J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1113 - 1118.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The American Association for Thoracic Surgery.